Intrapleural rituximab for the treatment of malignant pleural effusion due to B-cell lymphomas

Leuk Lymphoma. 2012 Jan;53(1):156-7. doi: 10.3109/10428194.2011.602769. Epub 2011 Aug 18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Drug Administration Routes
  • Humans
  • Lymphoma, B-Cell / complications
  • Lymphoma, B-Cell / drug therapy*
  • Male
  • Middle Aged
  • Pleural Effusion, Malignant / drug therapy*
  • Pleural Effusion, Malignant / etiology
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab